Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Photofrin Porfimer Sodium
Therapeutic Area : Oncology
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety of PDT-Photofrin® Prior to Lung Surgery
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 17, 2017
Lead Product(s) : Photofrin Porfimer Sodium
Therapeutic Area : Oncology
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Photofrin Porfimer Sodium
Therapeutic Area : Oncology
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 27, 2016
Lead Product(s) : Photofrin Porfimer Sodium
Therapeutic Area : Oncology
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Photofrin Porfimer Sodium
Therapeutic Area : Oncology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 10, 2014
Lead Product(s) : Photofrin Porfimer Sodium
Therapeutic Area : Oncology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Photofrin Porfimer Sodium
Therapeutic Area : Oncology
Study Phase : Phase II
Recipient : Harry T Whelan
Deal Size : Inapplicable
Deal Type : Inapplicable
Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 22, 2013
Lead Product(s) : Photofrin Porfimer Sodium
Therapeutic Area : Oncology
Highest Development Status : Phase II
Recipient : Harry T Whelan
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Photofrin Porfimer Sodium
Therapeutic Area : Oncology
Study Phase : Phase I
Recipient : Harry T Whelan
Deal Size : Inapplicable
Deal Type : Inapplicable
Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 11, 2012
Lead Product(s) : Photofrin Porfimer Sodium
Therapeutic Area : Oncology
Highest Development Status : Phase I
Recipient : Harry T Whelan
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Undisclosed
Therapeutic Area : Gastroenterology
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
December 08, 2010
Lead Product(s) : Undisclosed
Therapeutic Area : Gastroenterology
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
